- Home
- WLDS vs CVKD Comparison
WLDS vs CVKD Comparison
Compare WLDS & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WLDS | CVKD |
|---|---|---|
| Founded | 2014 | 2022 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9M | 9.9M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | WLDS | CVKD |
|---|---|---|
| Price | $1.64 | $4.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 58.3K | 40.4K |
| Earning Date | 03-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.94 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.64 | $4.21 |
| 52 Week High | $11.40 | $17.50 |
Technical Indicators
Market Signals| Indicator | WLDS | CVKD |
|---|---|---|
| Relative Strength Index (RSI) | 66.53 | 38.42 |
| Support Level | $1.05 | $4.21 |
| Resistance Level | $1.93 | $8.87 |
| Average True Range (ATR) | 0.12 | 0.52 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 96.30 | 38.35 |
Price Performance
Historical ComparisonAbout WLDS Wearable Devices Ltd.
Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.